The structures of the fibrinogen-like domains of Angptl3 and Angptl4 give new insights into these important proteins strongly linked to CAD, as well as offering the opportunity for the rational design of low molecular weight inhibitors of their function. The gene discussed is ANGPTL3; the disease is coronary artery disorder.